Cross Country Healthcare Inc (CCRN)
10.34
-0.04
(-0.39%)
USD |
NASDAQ |
Nov 22, 16:00
10.36
+0.02
(+0.15%)
After-Hours: 20:00
Cross Country Healthcare Enterprise Value: 276.34M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 276.34M |
| November 21, 2024 | 277.65M |
| November 20, 2024 | 272.06M |
| November 19, 2024 | 277.32M |
| November 18, 2024 | 276.34M |
| November 15, 2024 | 258.89M |
| November 14, 2024 | 265.47M |
| November 13, 2024 | 268.44M |
| November 12, 2024 | 299.05M |
| November 11, 2024 | 289.83M |
| November 08, 2024 | 277.00M |
| November 07, 2024 | 339.87M |
| November 06, 2024 | 335.92M |
| November 05, 2024 | 312.87M |
| November 04, 2024 | 305.30M |
| November 01, 2024 | 308.92M |
| October 31, 2024 | 311.56M |
| October 30, 2024 | 321.10M |
| October 29, 2024 | 325.71M |
| October 28, 2024 | 324.72M |
| October 25, 2024 | 316.82M |
| October 24, 2024 | 320.66M |
| October 23, 2024 | 321.64M |
| October 22, 2024 | 326.85M |
| October 21, 2024 | 327.50M |
| Date | Value |
|---|---|
| October 18, 2024 | 355.18M |
| October 17, 2024 | 367.56M |
| October 16, 2024 | 339.88M |
| October 15, 2024 | 337.27M |
| October 14, 2024 | 335.97M |
| October 11, 2024 | 337.60M |
| October 10, 2024 | 332.71M |
| October 09, 2024 | 334.99M |
| October 08, 2024 | 339.55M |
| October 07, 2024 | 342.48M |
| October 04, 2024 | 334.66M |
| October 03, 2024 | 352.25M |
| October 02, 2024 | 355.84M |
| October 01, 2024 | 362.68M |
| September 30, 2024 | 373.75M |
| September 27, 2024 | 376.33M |
| September 26, 2024 | 403.72M |
| September 25, 2024 | 386.48M |
| September 24, 2024 | 393.58M |
| September 23, 2024 | 405.75M |
| September 20, 2024 | 421.64M |
| September 19, 2024 | 436.18M |
| September 18, 2024 | 431.10M |
| September 17, 2024 | 416.23M |
| September 16, 2024 | 409.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
233.63M
Minimum
May 14 2020
1.520B
Maximum
Oct 28 2022
723.72M
Average
712.52M
Median
Jun 28 2021
Enterprise Value Benchmarks
| Ensign Group Inc | 7.965B |
| TransMedics Group Inc | 2.730B |
| CEL-SCI Corp | 36.25M |
| AIM ImmunoTech Inc | 8.915M |
| IGC Pharma Inc | 26.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.555M |
| Revenue (Quarterly) | 315.12M |
| Total Expenses (Quarterly) | 309.76M |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 20.36% |
| Profit Margin (Quarterly) | 0.81% |
| Earnings Yield | -0.48% |
| Operating Earnings Yield | 11.08% |
| Normalized Earnings Yield | 8.216 |